The U.S. Food and Drug Administration (FDA) has approved a label update for Cerenia (maropitant citrate), an FDA-approved veterinary antiemetic medication originally approved for use in dogs 16 weeks and older. Now, Cerenia Injectable Solution is also approved for treatment of vomiting in cats 16 weeks and older, and both the injectable and tablet formulations are approved for dogs 8 weeks and older for the prevention and treatment of acute vomiting.
The U.S. Food and Drug Administration Center for Veterinary Medicine (FDA-CVM) has approved an update to the labeling for Cerenia (maropitant citrate) tablets. The revised label now allows for once-daily administration until resolution of acute vomiting for dogs 7 months of age and older. Previously, the dosing and administration instructions limited use to five consecutive days for prevention of acute vomiting. The dosing limitation for use in dogs 2 to 7 months of age remains five consecutive days.
The FDA has also approved an update to the labeling for Cerenia (maropitant citrate) Injectable allowing for intravenous administration during surgical protocols using emetogenic medication, or medication that induces vomiting. Previously approved only for subcutaneous injection, this label update gives veterinarians the flexibility of an additional delivery option to help prevent vomiting in canine and feline patients.